Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
All Products
Displaying products by catalog number (0600 - 0699)
| 0100 | 0200 | 0300 | 0400 | 0500 | 0600 | 0700 | 0800 | 0900 | 1000 |
|---|---|---|---|---|---|---|---|---|---|
| 1100 | 1200 | 1300 | 1400 | 1500 | 1600 | 1700 | 1800 | 1900 | 2000 |
| 2100 | 2200 | 2300 | 2400 | 2500 | 2600 | 2700 | 2800 | 2900 | 3000 |
| 3100 | 3200 | 3300 | 3400 | 3500 | 3600 | 3700 | 3800 | 3900 | 4000 |
| 4100 | 4200 | 4300 | 4400 | 4500 | 4600 | 4700 | 4800 |
Cat.No. |
Product Name / Activity |
| 0600 | Nimodipine Ca2+ channel blocker (L-type) |
| 0601 | Nitrendipine Ca2+ channel blocker (L-type) |
| 0602 | 7-Nitroindazole Non-selective NOS inhibitor |
| 0603 | SNOG NO carrier. Breaks down to release NO |
| 0604 | Nicergoline α antagonist |
| 0605 | (±)-Octanoylcarnitine chloride Intermediate in lipid metabolism |
| 0606 | OBAA Phospholipase A2 inhibitor |
| 0607 | 17-ODYA LTB-ω-Hydroxylase inhibitor |
| 0609 | (±)-Palmitoylcarnitine chloride Protein kinase C inhibitor |
| 0610 | Parthenolide 5-HT release inhibitor |
| 0611 | (±)-Propionylcarnitine chloride Intermediate in lipid metabolism |
| 0616 | AG 556 EGFR-kinase inhibitor |
| 0618 | AG 555 Potent EGFR-kinase inhibitor |
| 0619 | AG 494 Potent EGFR-kinase inhibitor |
| 0620 | 4-PPBP maleate Specific σ ligand, NMDA antagonist |
| 0622 | Physostigmine hemisulfate Cholinesterase inhibitor |
| 0623 | Prazosin hydrochloride α1 and α2B antagonist. MT3 antagonist |
| 0624 | Propranolol hydrochloride β antagonist |
| 0625 | PPADS tetrasodium salt P2 purinergic antagonist |
| 0627 | 2-PMDQ Potent, selective α1 antagonist |
| 0629 | Quipazine dimaleate 5-HT3 agonist |
| 0630 | Rosmarinic acid Anti-inflammatory, cytostatic and antiviral; GPR35 agonist |
| 0631 | Spiroxatrine Potent α2C antagonist |
| 0633 | D-erythro-Sphingosine (synthetic) Protein kinase C inhibitor |
| 0634 | Salbutamol hemisulfate β agonist (β2 > β1) |
| 0635 | Synthalin sulfate Non-competitive NMDA antagonist |
| 0636 | Salsolinol-1-carboxylic acid Endogenous amino acid |
| 0638 | CGS 12066B dimaleate 5-HT1B agonist |
| 0640 | MDL 72222 5-HT3 antagonist |
| 0641 | Tropanyl-3,5-dimethylbenzoate 5-HT3 antagonist |
| 0644 | Thioperamide H3 antagonist and H4 inverse agonist |
| 0645 | 2-TEDC 5-, 12-, 15-Lipoxygenase inhibitor |
| 0646 | HTMT dimaleate H1 / H2 agonist |
| 0649 | (S)-Timolol maleate β1 antagonist |
| 0652 | Thalidomide TNF-α synthesis inhibitor |
| 0653 | (±)-Vesamicol hydrochloride Inhibits ACh transport |
| 0654 | Verapamil hydrochloride Ca2+ channel blocker (L-type) |
| 0655 | Zolpidem Benzodiazepine agonist |
| 0658 | FGIN-1-27 Potent, specific ligand for mitochondrial DBI receptor |
| 0659 | FGIN-1-43 Potent, specific ligand for mitochondrial DBI receptor |
| 0660 | Mepyramine maleate Selective H1 inverse agonist |
| 0661 | 2-MPMDQ Potent, selective α1 antagonist. Also σ2 ligand |
| 0662 | trans-Triprolidine hydrochloride Standard H1 antagonist, highly potent |
| 0663 | L-Arginine Endogenous substrate for NOS |
| 0664 | L-NNA NOS inhibitor (nNOS = eNOS >> iNOS) |
| 0665 | L-NAME hydrochloride Non-selective NOS inhibitor |
| 0666 | 3-AQC 5-HT3 antagonist |
| 0668 | Amthamine dihydrobromide Highly selective standard H2 agonist |
| 0670 | PK 11195 Antagonist at peripheral benzodiazepine receptors |
| 0671 | AH 6809 EP1 and EP2 receptor antagonist |
| 0673 | L-Canavanine sulfate NOS inhibitor |
| 0675 | NPC 15199 Increases intracellular Ca2+ levels |
| 0677 | Naltrexone hydrochloride Broad spectrum opioid antagonist |
| 0678 | (+)-AJ 76 hydrochloride Antagonist; preferential action at D2-like autoreceptors |
| 0680 | 2-Phenylmelatonin Potent melatonin agonist |
| 0681 | L-690,330 Inositol monophosphatase inhibitor |
| 0682 | L-690,488 Cell permeable prodrug of the IMPase inhibitor L-690,330 (Cat. No. 0681) |
| 0683 | iso-PPADS tetrasodium salt P2X antagonist |
| 0684 | (±)-Epibatidine Very potent nicotinic agonist |
| 0685 | Diltiazem hydrochloride Ca2+ channel blocker (L-type) |
| 0686 | Galanthamine hydrobromide Cholinesterase inhibitor |
| 0690 | Clonidine hydrochloride α2 agonist. Also I1 ligand |
| 0691 | Dipyridamole Adenosine transport inhibitor |
| 0692 | Ipratropium bromide Muscarinic antagonist |
| 0693 | Pancuronium dibromide Nicotinic (neuromuscular) antagonist |
| 0694 | Pilocarpine hydrochloride Muscarinic agonist |
| 0695 | Retinoic acid Endogenous retinoic acid receptor agonist. |
| 0699 | BRL 52537 hydrochloride Potent and selective κ agonist |
Products Alphabetically by Name
| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |
|---|
[top]
Quick Order
Find multiple products by catalog number
New Product Guide
Highlights over 130 new products added in 2012. Request a copy or view PDF today.
Tocris Events
Meet your representative
The Role of Cytokines and Signaling in Inflammation
October 15, 2013
Bonn, Germany